Peptides are a group of biologically active substances that are involved in various cellular functions of organisms.Peptides are frequently utilized in functional analysis, research on vaccines, and particularly in the production of pharmaceuticals. More than 80 peptide medications are already available on the market to treat a variety of illnesses, such as diabetes, cancer, osteoporosis, multiple sclerosis, HIV infection, and chronic pain.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V37051 | (Cit5)-TRAP-5 | 287184-84-3 | (Cit5)-TRAP-5 is a peptide compound. |
|
V36944 | (Cyclo(Glu22-Lys26),Leu27)-pTH (1-31) amide (human) | 188899-65-2 | (Cyclo(Glu22-Lys26),Leu27)-pTH (1-31) amide (human) is a peptide compound. |
|
|
V34939 | (Cys(Et)2·7)-α-CGRP (human) | 196413-73-7 | (Cys(Et)2·7)-α-CGRP (human) is a peptide compound. |
|
|
V36355 | (Cys-Antennapedia Homeobox (43-58) amide)-(Cys-FLAG-Cofilin (1-13) (human, mouse, porcine, rat)) | (Cys-Antennapedia Homeobox (43-58) amide)-(Cys-FLAG-Cofilin (1-13) (human, mouse, porcine, rat)) is a peptide compound. | |
|
|
V36868 | (Cys2)-Neuropeptide Y (1-4)-8-aminooctanoyl-(D-Cys27)-Neuropeptide Y (25-32)|C2-NPY | 128806-04-2 | (Cys2)-Neuropeptide Y (1-4)-8-aminooctanoyl-(D-Cys27)-Neuropeptide Y (25-32)|C2-NPY is a peptide compound. |
|
|
V36941 | (Cys8)-pTH (1-8) (human) | (Cys8)-pTH (1-8) (human) is a peptide compound. | |
|
|
V36718 | (Cys8·13)-Dynorphin A (1-13) amide | (Cys8·13)-Dynorphin A (1-13) amide is a peptide compound. | |
|
V37014 | (D-2-Nal5,Cys6·11,Tyr7,D-Trp8,Val10,2-Nal12)-Somatostatin-14 (5-12) amide | 111857-96-6 | BIM 23042 is a somatostatin (SS) octapeptide analog and a selective neuropeptide neuregulin B receptor (NMB-R, BB1) antagonist. |
|
|
V36711 | (D-Ala2)-Dynorphin A (1-9) | (D-Ala2)-Dynorphin A (1-9) is a peptide compound. | |
|
V36808 | (D-Ala2)-GRF (1-29) amide (human) | 89453-59-8 | (D-Ala2)-GRF (1-29) amide (human) is a superagonist of GRF and displays extremely high GH-releasing activity in pigs and rats, about 50 times that of GRF (1-29). |
|
|
V37088 | (D-Ala2)-β-Casomorphin (1-3) amide | (D-Ala2)-β-Casomorphin (1-3) amide is a peptide compound. | |
|
V35027 | (D-Ala2,D-Leu5)-Enkephalin amide | 66609-26-5 | (D-Ala2,D-Leu5)-Enkephalin amide is a peptide compound. |
|
V37093 | (D-Ala2,Hyp4,Tyr5)-β-Casomorphin (1-5) amide | 102029-98-1 | (D-Ala2,Hyp4,Tyr5)-β-Casomorphin (1-5) amide is a peptide compound. |
|
|
V37094 | (D-Ala2,Met5)-β-Casomorphin (1-5) amide (bovine) | (D-Ala2,Met5)-β-Casomorphin (1-5) amide (bovine) is a peptide compound. | |
|
V36714 | (D-Ala3)-Dynorphin A (1-11) amide | 160522-58-7 | (D-Ala3)-Dynorphin A (1-11) amide is a peptide compound. |
|
|
V37029 | (D-Ala4)-Substance P (4-11) | (D-Ala4)-Substance P (4-11) is a peptide compound. | |
|
V34923 | (D-Arg0,Hyp3,D-Phe7,Leu8)-Bradykinin | 135701-67-6 | (D-Arg0,Hyp3,D-Phe7,Leu8)-Bradykinin is a peptide compound. |
|
|
V37037 | (D-Arg1,D-Phe5,D-Trp7·11)-Substance P | (D-Arg1,D-Phe5,D-Trp7·11)-Substance P is a peptide compound. | |
|
V37038 | (D-Arg1,D-Phe5,D-Trp7·9,Leu11)-Substance P | 96736-12-8 | [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P is an analogue of substance P and a biased agonist of neuropeptide and chemokine receptors. |
|
V37039 | (D-Arg1,D-Pro2,D-Phe7,D-His9)-Substance P | 115760-58-2 | (D-Arg1,D-Pro2,D-Phe7,D-His9)-Substance P is a selective NK1 receptor blocker (antagonist). |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
